Women saw alarmingly high rates of mental health issues at start of COVID • Suburban Cook to expand vaccine eligibility • Prior authorizations still leading to delayed care
April 09, 2021 05:15 AM
Women saw alarmingly high rates of mental health issues at start of COVID • Suburban Cook to expand vaccine eligibility • Prior authorizations still leading to delayed care
Crain s Health Pulse is your source for actionable, exclusive and inside news on the health care industry.
Getty Images
WOMEN HAD HIGH RATE OF MENTAL HEALTH ISSUES AT START OF PANDEMIC: Women had higher rates of anxiety and depression at the beginning of the pandemic last year, according to a new study from UChicago Medicine.
COVID-19 in Illinois updates: Here s what s happening Friday chicagotribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chicagotribune.com Daily Mail and Mail on Sunday newspapers.
Suburban Cook had often matched its eligibility rollout to the city of Chicago. Both were limiting appointments to select vaccine groups to respond to what they said was low supply. Cook now tracks instead with the state and a majority of its counties. ?
As of April 5, the state’s Department of Public Health reported that 84 of Illinois’ 102 counties had expanded vaccine eligibility to all residents 16 and up. The state authorized all local health departments that were seeing early signs of unfilled appointments to start vaccinating everyone 16 and up at their discretion “in order to use their vaccine as quickly as possible and mitigate a rise in new COVID-19 cases.”
Vaccine Safety for Kids 6 Months and Up
Last week, Pfizer and BioNTech announced that in a Phase 3 trial in adolescents 12 to 15 years of age, “the Pfizer-BioNTech COVID-19 vaccine demonstrated 100% efficacy and robust antibody responses, exceeding those recorded earlier in vaccinated participants aged 16 to 25 years old, and was well tolerated.”
“We share the urgency to expand the authorization of our vaccine to use in younger populations and are encouraged by the clinical trial data from adolescents between the ages of 12 and 15,” said Albert Bourla, Chairman and Chief Executive Officer of Pfizer. “We plan to submit these data to FDA as a proposed amendment to our Emergency Use Authorization in the coming weeks and to other regulators around the world, with the hope of starting to vaccinate this age group before the start of the next school year.”
Oak Forest Election Results: City Council, Schools patch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from patch.com Daily Mail and Mail on Sunday newspapers.